Court maintains Medtronic owes Edwards $74M over CoreValve patent
The U.S. District Court for the District of Delaware reaffirmed an April 2010 federal jury decision that determined Medtronic's CoreValve willfully infringed Edwards Lifesciences’ Andersen transcatheter heart valve patent and awarded Edwards $74 million in damages.

In its ruling, the court denied Edwards’ request for a permanent injunction to prohibit Medtronic from manufacturing its CoreValve System in the U.S. Therefore, the Minneapolis-based Medtronic does not anticipate any interruption to supply of its CoreValve system, nor does it impact the Medtronic CoreValve U.S. pivotal trial, which began in December.

In the same ruling, the court denied Edwards' motions for increased damages and a permanent injunction relating to Medtronic CoreValve's willful infringement. Edwards plans to appeal these rulings promptly.

Medtronic said it “disagrees” with the court’s conclusion and also announced plans to appeal.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Philips introduced a new CT system at ECR aimed at the rapidly growing cardiac CT market, incorporating numerous AI features to optimize workflow and image quality.

Trimed Popup
Trimed Popup